Company news
Beijing Tiantan Biological Products Corporation Limited Class A (SSE:600161) news
Beijing Tiantan Biological Products Corporation Limited Class A news releases on 6ix. Latest, Sep 24, 2026: "BEIJING TIANTAN BIOLOGICAL PRODUCTS CO.…
View Beijing Tiantan Biological Products Corporation Limited Class A →
Press releases & updates
"BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD."Announcement on Resolutions of the 4th Meeting of the 10th Board of Directors
September 23, 2026
"BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026
September 16, 2026
"Beijing Tiantan Biological Products Corporation Limited"Announcement on Obtaining the Plasmapheresis Licenses by Subsidiaries
September 7, 2026
"Beijing Tiantan Biological Products Corporation Limited"Announcement on Resolutions of the 3rd Meeting of the 10th Board of Directors
August 28, 2026
"Beijing Tiantan Biological Products Corporation Limited"Announcement on Resolutions of the 2nd Meeting of the 10th Board of Directors
July 17, 2026
"Beijing Tiantan Biological Products Corporation Limited"Semi-annual Performance Forecast for 2026
July 14, 2026
Announcement on Resolutions of the 1st Meeting of the 10th Board of Directors
June 26, 2026
Announcement on Progress in Drug Clinical Trials of Subsidiaries
June 23, 2026
Announcement on Obtaining the Drug Registration Certificate by Subsidiary
June 8, 2026
Announcement on Resolutions of the 32nd Meeting of the 9th Board of Directors
June 4, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 22, 2026
Announcement on Resolutions of the 31st Meeting of the 9th Board of Directors
April 29, 2026
Announcement on Resolutions of the 30th Meeting of the 9th Board of Directors
March 27, 2026
Announcement on Subsidiary Once Again Obtaining the High-tech Enterprise Certificate
March 20, 2026
Announcement on Changes in Controlling Shareholder's Equity and Completion of Share Transfer Registration
March 6, 2026
Announcement on the Change of Project Quality Reviewer by Audit Institution
February 4, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
January 16, 2026
Notice on Convening the 1st Extraordinary General Meeting in 2026
December 31, 2025
Announcement on the Receipt of Clinical Trial Summary Report by a Subsidiary
December 4, 2025
Announcement on Resolutions of the 27th Meeting of the 9th Board of Directors
November 28, 2025
Indicative Announcement on Equity Change of Controlling Shareholder
November 24, 2025
Announcement on Withdrawal of Drug Registration Application by Subsidiary
November 19, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 4, 2025
Announcement on Resolutions of the 26th Meeting of the 9th Board of Directors
October 24, 2025
Announcement on Subsidiary Obtaining Drug GMP Compliance Inspection Notice and Changing Drug Production License
October 9, 2025
Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary
September 30, 2025
Announcement on Resignation of Senior Management Member
September 29, 2025
Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors
September 26, 2025
Announcement on Subsidiary Obtaining Drug GMP Compliance Inspection Notice
September 22, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
September 18, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 8, 2025
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
August 28, 2025
2025 Semi-annual Report
August 21, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
August 20, 2025
Brief Announcement on Semi-annual Earnings for 2025
August 6, 2025
Announcement on Waiving the Acquisition Opportunity of PLBIO
August 4, 2025
Announcement on Subsidiary Obtaining Notice of Approval for Drug Supplementary Application
July 23, 2025
Announcement on Resolutions of the 22nd Meeting of the 9th Board of Directors
June 30, 2025
Announcement on Subsidiary Obtaining Notice of GMP Compliance Inspection
June 24, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 13, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 27, 2025
Announcement on Postponement of 2024 Annual General Meeting
May 9, 2025
Announcement on Convening 2024 Annual Performance and Cash Dividend Meeting
April 28, 2025
Notice on Convening the 2024 Annual General Meeting
April 25, 2025
Announcement on Preliminary Earnings Estimate for Q1 2025
April 15, 2025
Announcement on Renewing Engagement of Accounting Firm
March 28, 2025
Announcement on Subsidiary Re-obtaining High-tech Enterprise Certificate
March 24, 2025
Announcement on Progress in Drug Clinical Trials of Subsidiary
March 4, 2025
Announcement on the Change of Sponsor Representative for Continuous Supervision
February 14, 2025
Announcement on Changing Signatory Certified Public Accountant
January 22, 2025